Rifabutin analogs for the treatment of bacterial diseases
Patent Information
- Application Number
- HK62026124963
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-02-10
- Filing Date
- 2026-06-17
- Publication Date
- 2026-09-11
Abstract
Description
Abstract This invention relates to compounds and pharmaceutical compositions comprising said compounds for the treatment, improvement, and / or prevention of diseases. In some embodiments, said disease is a bacterial infection. In some embodiments, said bacterial infection is caused by one or more bacteria belonging to the genus *Mycobacterium*, preferably *Mycobacterium abscessum*.
Claims
CLAIMS 1. A compound of Formula I or a pharmaceutically acceptable salt, tautomer, solvate, hydrate or enantiomer thereof: R1 N O wherein:R1 and R2 are each independently selected from -H, -C1-C6alkyl, -C3-C10cycloalkyl, C1-C6alkylene-C3-C10cycloalkyl, 3- to 15-membered heterocycloalkyl, -C1-C6alkylene-(3- to 15-membered heterocycloalkyl), -C6-C10 aryl, -C1-C6 alkylene-C6-C10 aryl, 5- to 10-membered heteroaryl, and -C1-C6 alkylene-(5- to 10-membered heteroaryl), wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R3; or R1 and R2, together with the nitrogen atom to which they are attached, combine to form a 5- to 15-membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more R4; R3 is independently, at each occurrence, -OH, halogen, -CN, -C1-C6 alkoxy, -C1-C6 alkyl, -C3-C10cycloalkyl, -C1-C6alkylene-C3-C10cycloalkyl, 3- to 15-membered heterocycloalkyl, -C1-C6alkylene-(3- to 15-membered heterocycloalkyl), -C6-C10aryl, -C1-C6alkylene-C6-C10 aryl, 5- to 10-membered heteroaryl, or -C1-C6 alkylene-(5- to 10-membered heteroaryl); wherein each cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more -OH, halogen, or C1-C6alkyl; R4 is independently, at each occurrence, -C 5 5 1-C6 alkyl, -OR , -C1-C6 alkylene-OR , -NR6R7, -C1-C6 alkylene-NR6R7, -C3-C10 cycloalkyl, -C1-C6 alkylene-C3-C10 cycloalkyl, 3- to 15-membered heterocycloalkyl, -C1-C6alkylene-(3- to 15-membered heterocycloalkyl), -C6- C10 aryl, -C1-C6 alkylene-C6-C10 aryl, 5- to 10-membered heteroaryl, or -C1-C6 alkylene-(5- to 10-membered heteroaryl), wherein each alkylene is optionally substituted with one or more oxo, and wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl is optionally substituted with one or more R8; R5 is independently, at each occurrence, -H, -C1-C6 alkyl, or -C1-C6 alkylene-OH; R6 and R7 are each independently, at each occurrence, -H, -C1-C6alkyl, -C3-C10cycloalkyl, 3- to 15-membered heterocycloalkyl, C6-C10aryl, or 5- to 10-membered heteroaryl; and R8 is independently, at each occurrence, -OH, halogen, or -C1-C6alkyl.
2. The compound of claim 1, wherein R1 and R2 are each independently selected from -H, -C1-C4 alkyl, -C3-C10 cycloalkyl, C1-C4 alkylene-C3-C10 cycloalkyl, -5- to 15-membered heterocycloalkyl, and -C1-C4alkylene-(5- to 15-membered heterocycloalkyl), wherein each alkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R3; or R1 and R2, together with the nitrogen atom to which they are attached, combine to form a 5- to 15-membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more R4; R3 is independently, at each occurrence, -OH, halogen, -C1-C4 alkyl, -C3-C10 cycloalkyl, -C1-C4 alkylene-C3-C10 cycloalkyl, 5- to 15-membered heterocycloalkyl, -C1-C4 alkylene-(5- to 15-membered heterocycloalkyl), -C6-C10aryl, -C1-C4alkylene-C6-C10aryl, 5- to 10-membered heteroaryl, or -C1-C4alkylene-(5- to 10-membered heteroaryl); wherein each cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more -OH, halogen, or C1-C4 alkyl; R4 is independently, at each occurrence, -C 5 5 1-C6 alkyl, -OR , -C1-C4 alkylene-OR , - NR6R7, -C1-C4 alkylene-NR6R7, -C3-C10 cycloalkyl, -C1-C4 alkylene-C3-C10 cycloalkyl, 5- to 15-membered heterocycloalkyl, -C1-C4alkylene-(5- to 15-membered heterocycloalkyl), -C6- C10 aryl, -C1-C4 alkylene-C6-C10 aryl, 5- to 10-membered heteroaryl, or -C1-C4 alkylene-(5- to 10-membered heteroaryl), wherein each alkylene is optionally substituted with one or more oxo; and wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl is optionally substituted with one or more R8; R5is independently, at each occurrence, -H, -C1-C4alkyl, or -C1-C4alkylene-OH;R6 and R7 are each independently, at each occurrence, -H, -C1-C4 alkyl, -C3-C10 cycloalkyl, 5- to 10-membered heterocycloalkyl, C6-C10aryl, or 5- to 10-membered heteroaryl; and R8is independently, at each occurrence, -OH, halogen, or -C1-C4alkyl.
3. The compound of claim 1 or 2, wherein R1 and R2 are each independently selected from -H, -5- to 15-membered heterocycloalkyl, and -C1-C4 alkylene-(5- to 15-membered heterocycloalkyl), wherein each heterocycloalkyl is optionally substituted with one or more R3; or R1and R2, together with the nitrogen atom to which they are attached, combine to form a 5- to 15-membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more R4; R3 is independently, at each occurrence, -OH, halogen, -C1-C4alkyl, -C3-C10cycloalkyl, -C1-C4 alkylene-C3-C10 cycloalkyl, 5- to 15-membered heterocycloalkyl, -C1-C4 alkylene-(5- to 15-membered heterocycloalkyl), -C6-C10aryl, -C1-C4alkylene-C6-C10aryl, 5- to 10-membered heteroaryl, or -C1-C4 alkylene-(5- to 10-membered heteroaryl); wherein each cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more -OH, halogen, or C1-C4alkyl; R4 is independently, at each occurrence, -C1-C6alkyl, -OR5, -C1-C4alkylene-OR5, - NR6R7, -C1-C4 alkylene-NR6R7, -C3-C10 cycloalkyl, -C1-C4 alkylene-C3-C10 cycloalkyl, 5- to 15-membered heterocycloalkyl, -C1-C4 alkylene-(5- to 15-membered heterocycloalkyl), -C6- C10aryl, -C1-C4alkylene-C6-C10aryl, 5- to 10-membered heteroaryl, or -C1-C4alkylene-(5- to 10-membered heteroaryl), wherein each alkylene is optionally substituted with one or more oxo; and wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl is optionally substituted with one or more R8; R5 is independently, at each occurrence, -H, -C1-C4 alkyl, or -C1-C4 alkylene-OH; R6and R7are each independently, at each occurrence, -H, -C1-C4 alkyl, -C3-C10 cycloalkyl, 5- to 6-membered heterocycloalkyl, C6-C10aryl, or 5- to 10-membered heteroaryl; and R8 is independently, at each occurrence, halogen or -C1-C4 alkyl.
4. The compound of any of claims 1 to 3, wherein R1 and R2 are each independently selected from -H, -C1-C6alkyl, -C3-C6cycloalkyl, C1-C6alkylene-C3-C6cycloalkyl, -5- to 6-membered heterocycloalkyl, -C1-C6 alkylene-(5- to 6-membered heterocycloalkyl), -C6-C10 aryl, -C1-C6alkylene-C6-C10aryl, 5- to 6-membered heteroaryl, or -C1-C6alkylene-(5- to 6- membered heteroaryl), wherein each cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R3.
5. The compound of any of claims 1 to 4, wherein R1 and R2 are each independently selected from -H, -5- to 12-membered heterocycloalkyl, and -C1-C4 alkylene-(5- to 12- membered heterocycloalkyl), wherein each heterocycloalkyl is optionally substituted with one or more R3; and R3is independently, at each occurrence, -C1-C4 alkyl, -C3-C10 cycloalkyl, -C1-C4 alkylene-C3-C10cycloalkyl, 5- to 12-membered heterocycloalkyl, -C1-C4alkylene-(5- to 12- membered heterocycloalkyl), -C6-C10 aryl, -C1-C4 alkylene-C6-C10 aryl, 5- to 10-membered heteroaryl, or -C1-C4alkylene-(5- to 10-membered heteroaryl); wherein each cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more C1-C4 alkyl.
6. The compound of any of claims 1 to 5, wherein R1is -H; R2 is independently selected from -5- to 6-membered heterocycloalkyl and -C1-C2 alkylene-(5- to 6-membered heterocycloalkyl), wherein each heterocycloalkyl is optionally substituted with one or more R3; and R3 is independently, at each occurrence, -C1-C4 alkyl, -C3-C6 cycloalkyl, -C1-C2 alkylene-C3-C6 cycloalkyl, 5- to 6-membered heterocycloalkyl, -C1-C2 alkylene-(5- to 6- membered heterocycloalkyl), -C6- aryl, -C1-C2alkylene-C6aryl, 5- to 6-membered heteroaryl, or -C1-C2 alkylene-(5- to 6-membered heteroaryl); wherein each cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more C1-C2alkyl.
7. The compound of any of claims 1 to 3, wherein R1 and R2, together with the nitrogen atom to which they are attached, combine to form a 5- to 15-membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more R4.
8. The compound of any of claims 1 to 3 or 7, wherein R1 and R2, together with the nitrogen atom to which they are attached, combine to form a 5- to 12-membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more R4; R4is independently, at each occurrence, -C1-C6alkyl, -OR5, -C1-C4alkylene-OR5, -NR6R7, -C1-C4 alkylene-NR6R7, -C5-C10 cycloalkyl, -C1-C4 alkylene-C5-C10 cycloalkyl, 5- to 12-membered heterocycloalkyl, -C1-C4alkylene-(5- to 12-membered heterocycloalkyl), phenyl, -C1-C4 alkylene-phenyl, 5- to 10-membered heteroaryl, or -C1-C4 alkylene-(5- to 10- membered heteroaryl), wherein each alkylene is optionally substituted with one or more oxo; and wherein each alkyl, cycloalkyl, heterocycloalkyl, phenyl or heteroaryl is optionally substituted with one or more R8; R5 is independently, at each occurrence, -H, -C1-C4 alkyl, or -C1-C4 alkylene-OH; R6 and R7 are each independently, at each occurrence, -H, -C1-C4alkyl, -C5-C6cycloalkyl, 5- to 6-membered heterocycloalkyl, phenyl, or 5- to 6-membered heteroaryl; and R8is independently, at each occurrence, halogen or -C1-C4 alkyl.
9. The compound of any of claims 1 to 3 or 7 to 8, wherein R1 and R2, together with the nitrogen atom to which they are attached, combine to form a 6- to 7-membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more R4; R4 is independently, at each occurrence, -C1-C6alkyl, -OR5, -C1-C4alkylene-OR5, - NR6R7, -C1-C4 alkylene-NR6R7, -C5-C6 cycloalkyl, -C1-C4 alkylene-C5-C6 cycloalkyl, 5- to 6- membered heterocycloalkyl, -C1-C4 alkylene-(5- to 6-membered heterocycloalkyl), phenyl, - C1-C4alkylene-phenyl, 5- to 6-membered heteroaryl, or -C1-C4alkylene-(5- to 6-membered heteroaryl), wherein each alkylene is optionally substituted with one or more oxo; and wherein each alkyl, cycloalkyl, heterocycloalkyl, phenyl or heteroaryl is optionally substituted with one or more R8; R5 is independently, at each occurrence, -H, -C1-C4alkyl, or -C1-C4alkylene-OH; R6 and R7 are each independently, at each occurrence, -H, -C1-C4 alkyl, -C5-C6 cycloalkyl, 5- to 6-membered heterocycloalkyl, phenyl, or 5- to 6-membered heteroaryl; and R8 is independently, at each occurrence, halogen or -C1-C4 alkyl.
10. The compound according to claim 1, wherein the compound is selected from the groupconsisting of:
11. The compound according to claim 1, wherein the compound is selected from the groupconsisting of:or a pharmaceutically acceptable salt thereof.
12. The compound according to claim 1, wherein the compound is selected from the groupconsisting of:or a pharmaceutically acceptable salt thereof.
13. A pharmaceutical composition comprising at least one compound according to any of the preceding claims, or a pharmaceutically acceptable salt, tautomer, solvate or hydrate thereof, and a pharmaceutically acceptable excipient.
14. A compound according to any of the claims 1 to 12 or a pharmaceutically acceptable salt, tautomer, solvate or hydrate thereof, for use as a medicament.
15. A compound of according to any of the claims 1 to 12 or a pharmaceutically acceptable salt, tautomer, solvate or hydrate thereof, for use in a method of preventing or treating a disease in a subject, preferably wherein said disease is an infection, further preferably a bacterial infection, yet further preferably a bacterial infection caused by one or more bacterium belonging to a genus of non-tuberculous Mycobacteria, preferably M. abscessus.
